Basic information Safety Supplier Related

Crisnatol

Basic information Safety Supplier Related

Crisnatol Basic information

Product Name:
Crisnatol
Synonyms:
  • Crisnatol
  • 2-(Chrysene-6-ylmethylamino)-2-methyl-1,3-propanediol
  • 2-[(Chrysen-6-ylmethyl)amino]-2-methyl-1,3-propanediol
  • 770U-82
  • BW-A-770U
  • 1,3-Propanediol, 2-((6-chrysenylmethyl)amino)-2-methyl-
  • Crisnatol [inn]
  • Crisnatolum
CAS:
96389-68-3
MF:
C23H23NO2
MW:
345.43
Mol File:
96389-68-3.mol
More
Less

Crisnatol Chemical Properties

form 
Solid
color 
White to off-white
More
Less

Crisnatol Usage And Synthesis

Uses

Crisnatol (BWA770U) is an orally active and anticancer agent, and a member of the arylmethylaminopropanediol class of DNA intercalators. Crisnatol shows in vitro cytotoxicity against human breast cancer cells, but not normal human skin fibroblasts[1][2][3].

in vivo

Crisnatol (25 mg/kg; p.o.; single dose) shows oral activity and shows stable metabolite profile extract of rat feces by autoradiography[2].

References

[1] Adams DJ. In vitro pharmacodynamic assay for cancer drug development: application to crisnatol, a new DNA intercalator. Cancer Res. 1989 Dec 1;49(23):6615-20. PMID:1676660
[2] Patel DK, et al. Metabolism of a novel antitumor agent, crisnatol, by a human hepatoma cell line, Hep G2, and hepatic microsomes. Characterization of metabolites. Biochem Pharmacol. 1991 Jul 5;42(2):337-46. DOI:10.1016/0006-2952(91)90721-g
[3] Patel DK, et al. Disposition, metabolism, and excretion of the anticancer agent crisnatol in the rat. Drug Metab Dispos. 1991 Mar-Apr;19(2):491-7. PMID:1676660

CrisnatolSupplier

LGM Pharma
Tel
1-(800)-881-8210
Email
inquiries@lgmpharma.com
TargetMol Chemicals Inc.
Tel
4008200310
Email
marketing@tsbiochem.com
Shanghai Yifei Biotechnology Co. , Ltd.
Tel
021-65675885 18964387627
Email
customer_service@efebio.com
RD International Technology Co., Limited
Tel
18024082417
Email
market@ubiochem.com
Jiangsu Aikon Biopharmaceutical R&D Co.,Ltd.
Tel
025-66061636 18013972705
Email
qqyang@aikonchem.com
More
Less